Weekly Recap | Tesla +6.02%, Robotaxi approval sparks rally
I'm LongbridgeAI, I can summarize articles.Tesla (TSLA) rallied 6.02% this week to close at $362.86, decisively outperforming the S&P 500, which fell 1.43% — a relative gain of roughly 7.45 percentage points. The week was marked by sharp swings and a 10.38% amplitude. Early pressure pushed the stock to a low of $331.12 by Tuesday (18 Aug), but sentiment turned midweek, with a 4% bounce on Wednesday (19 Aug).
The Week
Tesla (TSLA) rallied 6.02% this week to close at $362.86, decisively outperforming the S&P 500, which fell 1.43% — a relative gain of roughly 7.45 percentage points. The week was marked by sharp swings and a 10.38% amplitude. Early pressure pushed the stock to a low of $331.12 by Tuesday (18 Aug), but sentiment turned midweek, with a 4% bounce on Wednesday (19 Aug). The real catalyst arrived on Friday (21 Aug), when news of a Robotaxi approval in Nevada sent the stock surging to a weekly high of $366.50 on elevated volume, before settling at $362.86.
Key Events
The week’s narrative was dominated by three storylines: a regulatory green light for Robotaxis, the end of the Solar Roof, and a record recall in China. On Friday, Nevada approved a deployment of up to 5,000 Tesla Robotaxis in Las Vegas, a move the market treated as a tangible step toward commercialising autonomous ride-hailing. The stock jumped over 5% on the day. At the same time, Tesla confirmed it is discontinuing its Solar Roof tiles, citing a lack of economic viability — a strategic retreat from its energy product lineup.
In China, regulators ordered the country’s largest-ever auto recall, covering Tesla and several other brands, over concerns that flush door handles could fail to present after a crash, trapping occupants. Tesla will deploy a software fix for over 2 million locally made and imported vehicles, adding driver-monitoring features. Despite the headline scale of the recall, the stock barely flinched, suggesting the market is prioritising the Robotaxi story over near-term operational drag. Elsewhere, Tesla confirmed its Semi electric truck will be showcased at the IAA in Europe, flagging a new market push.
Analyst Ratings
A total of 50 analysts currently cover Tesla, with 22 assigning a buy or overweight rating (including 16 strong buys and 6 overweight), 19 holding a neutral view, and 5 at underweight or sell. The consensus recommendation is a ‘buy’, with a consensus target price of $390.09, implying roughly 7.5% upside from the latest close of $362.86. Target estimates remain extraordinarily wide, ranging from $125 to $600, underscoring deep disagreement about the stock’s long-term value. Within the automobile manufacturer industry, Tesla ranks first out of 30 peers in terms of analyst consensus strength, indicating a relatively high level of institutional backing.
The Week Ahead
The macro calendar turns to US housing data on Tuesday (25 Aug), with the FHFA House Price Index, the Case-Shiller 20-City Composite, and new home sales figures all due. For Tesla specifically, the next catalysts are likely to be more details on the Las Vegas Robotaxi rollout timeline and the Semi truck’s European market entry. Investors will also keep an eye on the progress of the software update tied to the China recall, and whether it introduces any friction into third-quarter delivery numbers.
In Short
Tesla navigated a dramatic week, absorbing a massive recall while riding a Robotaxi approval to a strong weekly gain. The stock currently sits at a crossroads: Robotaxi and Semi offer fresh catalysts that keep the consensus rating at ‘buy’ and the target price above spot, while the Solar Roof wind-down and the China recall highlight the cost of experimentation. At roughly 358x trailing earnings, the valuation leaves little room for slippage. The next leg of the story will hinge on whether Robotaxi moves from regulatory approval to verifiable operational data, and whether core vehicle deliveries can hold the line in an increasingly competitive market.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
